These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 30229828

  • 1. MiR-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting ATF2.
    Shen YY, Cui JY, Yuan J, Wang X.
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5554-5561. PubMed ID: 30229828
    [Abstract] [Full Text] [Related]

  • 2. Regulation by Pink1 on the mitochondrial dysfunction in endothelial cells post the hypoxia mimetic agent CoCl2 treatment.
    Liu GH, Wen Y, Yang P, Liu GF.
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5704-5711. PubMed ID: 30229848
    [Abstract] [Full Text] [Related]

  • 3. miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2.
    Zhang S, Gao L, Thakur A, Shi P, Liu F, Feng J, Wang T, Liang Y, Liu JJ, Chen M, Ren H.
    Tumour Biol; 2016 Aug; 37(8):11177-86. PubMed ID: 26935060
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y, Xiao G, Chen Y, Deng Y.
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
    Zhang MY, Lin J, Kui YC.
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
    Wang H, Guan X, Tu Y, Zheng S, Long J, Li S, Qi C, Xie X, Zhang H, Zhang Y.
    J Exp Clin Cancer Res; 2015 Jun 11; 34(1):59. PubMed ID: 26063204
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MiR-141 promotes cell proliferation and invasion in non-small cell lung cancer by targeting KLF9.
    Kong YJ, Tan XX, Zhang Y, He QJ, Zhao L, Meng Q.
    Eur Rev Med Pharmacol Sci; 2019 Dec 11; 23(23):10370-10378. PubMed ID: 31841191
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
    Yang WB, Zhang WP, Shi JL, Wang JW.
    Eur Rev Med Pharmacol Sci; 2018 Jun 11; 22(11):3408-3414. PubMed ID: 29917192
    [Abstract] [Full Text] [Related]

  • 18. miRNA-451a regulates RPE function through promoting mitochondrial function in proliferative diabetic retinopathy.
    Shao Y, Dong LJ, Takahashi Y, Chen J, Liu X, Chen Q, Ma JX, Li XR.
    Am J Physiol Endocrinol Metab; 2019 Mar 01; 316(3):E443-E452. PubMed ID: 30576241
    [Abstract] [Full Text] [Related]

  • 19. miR-425 regulates cell proliferation, migration and apoptosis by targeting AMPH-1 in non-small-cell lung cancer.
    Jiang L, Ge W, Geng J.
    Pathol Res Pract; 2019 Dec 01; 215(12):152705. PubMed ID: 31685299
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.
    Liu XH, Lu KH, Wang KM, Sun M, Zhang EB, Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, De W, Wang ZX.
    BMC Cancer; 2012 Aug 09; 12():348. PubMed ID: 22876840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.